Meds & supplements › Sarecycline
Medicine
SEYSARA ® (sarecycline) tablet, is indicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Limitations of Use Efficacy of SEYSARA beyond 12 weeks and safety beyond 12 months have not been established. SEYSARA has not been evaluated in the treatment of infections.
To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, SEYSARA should be used only as indicated.
SEYSARA is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.
Storage
Store at 20°C - 25°C (68°F - 77°F); excursions permitted to 15°C - 30°C (59°F - 86°F).
Handling
Protect from moisture and excessive heat.
The recommended dosage of SEYSARA is based on body weight described in Table 1. If there is no improvement after 12 weeks, reassess treatment with SEYSARA.
Take SEYSARA once daily, with or without food. To reduce the risk of esophageal irritation and ulceration, administer SEYSARA with adequate amounts of fluid.
sofidex [Internet]. Daloreum; c2026. Sarecycline; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/sarecycline
sofidex. (2026, August 3). Sarecycline. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/sarecycline
Sarecycline. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/sarecycline
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.